Results 121 to 130 of about 32,253 (267)

Beyond Traditional Screening: The Future of Heart Failure Detection With Biomarkers and AI

iNew Medicine, EarlyView.
Advancing HF Screening: Integrating Technology and Risk Factors Across Eras. This diagram provides a comprehensive review of the historical developments and projected trends of heart failure (HF) screening methodologies, with the prevalent risk factors for HF depicted at the base.
Xiaofeng Fang, Yinbo Xu, Yiting Zhao, Liuyi Li, Zhengyi Cheng, Zhongqi Zhang, Yuhang Luo, Qiaoling Liu, Chen Gong, Shichun Shen   +9 more
wiley   +1 more source

Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE-AF registry. [PDF]

, 2019
BackgroundIn non-valvular atrial fibrillation (NVAF) patients, congestive heart failure (CHF) confers an increased risk of stroke or systemic thromboembolism.
Cannon, Christopher P, Castillo, Javier, Contreras, Johanna P, Hong, Kimberly N, Hsu, Jonathan C, Maddox, Thomas M, Marzec, Lucas N, Yang, Song   +7 more
core   +1 more source

Inflammation, Immunity, and Cardiovascular Diseases

Med Research, EarlyView.
Cardiovascular stress signals (e.g., hemodynamic shear, oxidized lipids, and ischemia) act on endothelial and immune cells to activate and amplify inflammation through NF‐κB, the NLRP3 inflammasome, and JAK/STAT signaling, inducing proinflammatory cytokines/chemokines (IL‐6, IL‐1β, TNF‐α, and CCL2) and self‐amplifying circuits; clinically, inflammatory
Dezhi Guo, Yan Liao, Rui Zhao, Zhaoyu Li, Kaikai Wang, Haoling Zhang, Pingxin Sun, Yadong Guo, Wangzheqi Zhang   +8 more
wiley   +1 more source

Comparative analysis of serum galanin levels in patients with coronary artery disease with and without heart failure with reduced ejection fraction and in individuals without cardiovascular diseases

Кардиоваскулярная терапия и профилактика
Aim. To study the level of the neuro-regulatory peptide galanin in pa­tients with coronary artery disease (CAD) with and without heart failu­re with reduced ejection fraction (HFrEF) in comparison with individuals without cardiovascular disease (CVD ...
Yu. S. Timofeev, A. A. Yafarova, A. F. Sheptulina, A. R. Kiselev, V. A. Metelskaya, N. I. Dubovskaya, O. M. Drapkina   +6 more
doaj   +1 more source

Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio‐oncology Registry

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Immune checkpoint inhibitors (ICI) have revolutionized cancer therapy, offering improvements in survival across various malignancies. However, their toxicities pose a major challenge for cardio‐oncology units. Despite their growing importance, data on effectiveness of such specialized units in mitigating ICI‐associated ...
Elias Haj‐Yehia, Lisa Zimmer, Lena Lampe, Dimitra Vlachopoulou, Matthias Totzeck, Tienush Rassaf, Raluca I. Mincu   +6 more
wiley   +1 more source

C1q/TNF-related protein 3 (CTRP3) and 9 (CTRP9) concentrations are decreased in patients with heart failure and are associated with increased morbidity and mortality. [PDF]

, 2019
BACKGROUND: Biochemical marker has revolutionized the approach to the diagnosis of heart failure. However, it remains difficult to assess stability of the patient. As such, novel means of stratifying disease severity are needed. C1q/TNF-Related Protein 3
Fu, Feng, Gao, Chao, Lian, Kun, Ma, Xin-Liang, Mi, Baibing, Si, Rui, Tan, Zhijun, Tao, Ling, Wang, Rutao, Wang, Shuai, Zhao, Shasha   +10 more
core   +1 more source

Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular‐Kidney‐Metabolic Syndrome

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Cardiovascular‐kidney‐metabolic (CKM) syndrome is defined by the pathologic interconnections between obesity, diabetes, chronic kidney disease and cardiovascular disease. An important and underrecognized pathophysiologic factor underlying CKM syndrome is obesity‐induced aldosterone excess.
Evan Zeitler, Klara R. Klein, Ildiko Lingvay, Anthony Pick, Liana K. Billings   +4 more
wiley   +1 more source

Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction

ESC Heart Failure
Aims Heart failure represents a substantial burden to both patients and healthcare systems worldwide. Nitric oxide (NO) dysregulation may play a key role in patients transitioning from chronic to acute heart failure with a reduced ejection fraction ...
Roman Falls, Bing H. Wang, Sara Vogrin, Christopher J. Neil   +3 more
doaj   +1 more source

The Resynchronization Effect in Left Bundle Branch Pacing Can be Evaluated Non‐Invasively With the Implementation of Lead V8

Journal of Cardiovascular Electrophysiology, EarlyView.
The negative derivative activation time (NDAT) of the surface electrode positioned at V8 closely corresponds to the left ventricular electrical delay to the left ventricular lead within the coronary sinus during intrinsic rhythm, and during all left bundle branch area pacing subtypes (right ventricular septal pacing (RVSP), deep septal pacing (DSP ...
Vadivelu Ramalingam, Johan van Koll, Peter Tai, Vidal Essebag, Atul Verma, Uyên C. Nguyên, Joost Lumens, Justin G. L. M. Luermans, Kevin Vernooy, Jacqueline Joza   +9 more
wiley   +1 more source

Comparing outcomes after pulmonary vein isolation in patients with systolic and diastolic heart failure

Heart Rhythm O2
Background: The benefit of pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) is well established; its efficacy in patients with heart failure preserved ejection fraction ...
Ahmad B. Allaw, MD, Jeremy Treger, MD, PhD, Jia Guo, MD, Dipayon Roy, MD, Amulya Gampa, MD, Swati Rao, MD, Stephanie A. Besser, MSAS, Andrew D. Beaser, MD, Zaid Aziz, MD, Cevher Ozcan, MD, Srinath Yeshwant, MD, Gaurav A. Upadhyay, MD   +11 more
doaj   +1 more source